Total Hip Arthroplasty
0
Pipeline Programs
3
Companies
6
Clinical Trials
3 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
MedactaSwitzerland - Castel San Pietro
4 programsEBRA Study AMISTEM-C FRN/A1 trial
Mpact 3D metal MONOCER cupN/A1 trial
Mpact 3D metal cupN/A1 trial
Multicenter Mpact DM FranceN/A1 trial
Active Trials
+1 more trials
J&
Johnson & JohnsonNEW BRUNSWICK, NJ
1 programTotal hip replacement with titanium shell and CORAIL stemN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
MedactaMpact 3D metal MONOCER cup
MedactaMpact 3D metal cup
MedactaMulticenter Mpact DM France
MedactaEBRA Study AMISTEM-C FR
CorinMiniHip Stem
Johnson & JohnsonTotal hip replacement with titanium shell and CORAIL stem
Clinical Trials (6)
Total enrollment: 88 patients across 6 trials
A Post Market Surveillance Study About the MONOCER Cup
Start: Jan 2022Est. completion: Feb 2050
N/ARecruiting
N/ARecruiting
Multicenter Mpact DM France
Start: Apr 2018Est. completion: Apr 2031
N/ARecruiting
EBRA Study AMISTEM-C FR
Start: Feb 2017Est. completion: Feb 2029
N/AActive Not Recruiting
Corin MiniHip and Trinity Cup Clinical Surveillance Study
Start: Mar 2011Est. completion: May 2028
N/AActive Not Recruiting
A Clinical Trial of a Metal on Poly Component Versus CORAIL Stem: A Bone Mineral Density Study
Start: Apr 2010Est. completion: Nov 202088 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 actively recruiting trials targeting 88 patients
3 companies competing in this space